drugset / Trial / NCT03840278

The Bihormonal iLet Bionic Pancreas Feasibility Study

NCT03840278

RandomizedCrossoverOpen-labelTreatment

Summary

Our objective is to evaluate the function of the bihormonal configuration of the ILet bionic pancreas delivering dasiglucagon when compared to the insulin-only configuration of the ILet bionic pancreas in a home-use study in adults with type 1 diabetes.

Timeline

Start
2019-05-15
Primary completion
2019-07-03
Completion
2019-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dasiglucagon Peptide